gadolinium dtpa has been researched along with 18f-fluoroethyl-l-tyrosine in 3 studies
Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (18f-fluoroethyl-l-tyrosine) | Trials (18f-fluoroethyl-l-tyrosine) | Recent Studies (post-2010) (18f-fluoroethyl-l-tyrosine) |
---|---|---|---|---|---|
12,654 | 664 | 4,051 | 122 | 8 | 112 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coenen, HH; Ewelt, C; Felsberg, J; Floeth, FW; Langen, KJ; Reifenberger, G; Sabel, M; Steiger, HJ; Stoffels, G; Stummer, W | 1 |
Ewelt, C; Felsberg, J; Floeth, FW; Langen, KJ; Sabel, M; Steiger, HJ; Stoffels, G; Stummer, W | 1 |
Avril, N; Hoimes, C; Hu, L; Lee, Z; Muzic, R; Sher, A; Valls, L | 1 |
1 trial(s) available for gadolinium dtpa and 18f-fluoroethyl-l-tyrosine
Article | Year |
---|---|
Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas.
Topics: Adult; Aged; Aminolevulinic Acid; Blood-Brain Barrier; Brain Neoplasms; Female; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Spectrometry, Fluorescence; Tyrosine | 2011 |
2 other study(ies) available for gadolinium dtpa and 18f-fluoroethyl-l-tyrosine
Article | Year |
---|---|
Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.
Topics: Adult; Aminolevulinic Acid; Biopsy; Brain Neoplasms; Carcinoma; Contrast Media; Female; Fluorescence; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Intraoperative; Neurosurgical Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Surgery, Computer-Assisted; Tyrosine | 2011 |
Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium DTPA; Humans; Image Enhancement; Indoles; Kidney Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrroles; Radiopharmaceuticals; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine | 2014 |